Glossary

Anticholinergic Burden

Anticholinergic burden is the combined effect of taking one or more medicines with anticholinergic properties. A higher burden is linked to falls, confusion and cognitive decline, especially in older people and people living with frailty.

Clinically reviewed by Aisha Malik, Clinical Director (GPhC 2205843), on .

What it means in practice

Many common medicines have anticholinergic effects, including some used for overactive bladder, depression, allergy and Parkinson's disease. PrescQIPP's bulletin on anticholinergic burden notes that a growing number of systematic reviews link these medicines to cognitive impairment, falls and all-cause mortality in older people, and recommends prescribing them with caution in older people and people with frailty, reviewing them regularly, and stopping or switching to a lower-burden option where there's no absolute need. Several scales score the burden, such as the Anticholinergic Cognitive Burden (ACB) scale; there is no single standard scale. Because the burden builds up across several prescriptions, it's a common focus of structured medication reviews.

Good practice

  • Calculate the anticholinergic burden at medication reviews for older people and people with frailty
  • Avoid prescribing anticholinergics alongside acetylcholinesterase inhibitors
  • Stop or switch to a lower-burden option where there's no clear need
  • Review after a fall or a new episode of confusion

Questions

Which scale should I use to measure anticholinergic burden?

There's no single standard scale. The Anticholinergic Cognitive Burden (ACB) scale is widely used; use the one your local guidance recommends and be consistent.

Sources

Checked against these sources on 19 November 2026.

  1. Anticholinergic burden, bulletin 253 (PrescQIPP)
  2. Anticholinergic burden measures and older people's falls risk: a systematic prognostic review (Therapeutic Advances in Drug Safety, 2021)

Remote clinical pharmacists, funded through ARRS.

Book a 30-minute call